Effects of RBM15B on proliferation and invasion of pancreatic cancer cells and underlying mechanism
谭淳中,夏鹏,郭德良,杨张朔,刘朋朋,张浩,刘志苏
DOI: https://doi.org/10.3760/cma.j.cn421213-20210904-01257
2022-01-01
Abstract:Objective:To observe the expression of RNA-binding motif protein 15B (RBM15B) in pancreatic cancer (PC) and explore its relationship with the proliferation, invasion of pancreatic cancer cells.Methods:Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting were used to detect the mRNA and protein expression of RBM15B in 80 cases of PC tissues, adjacent tissues, two pancreatic cancer cell lines (SW1990, HPAFII) and human normal pancreatic cells (HPDE). The experimental group was transfected with sh1-RBM15B and sh2-RBM15B, and the control group was transfected with sh-NC. After two weeks of puromycin selection, stable knockdown RBM15B and control cell lines were obtained. The cell counting kit-8 (CCK-8) proliferation assay and clone formation assay were used to detect cell proliferation ability. Cell invasion ability was measured by Transwell invasion assay. The comparison between the two groups was performed by independent samples
t test and
χ2 test.
Results:The protein expression of RBM15B was significantly up-regulated in pancreatic cancer tissues as compared with adjacent tissues (2.87±0.41 vs. 1.07±0.38,
t=5.623,
P<0.01). RBM15B mRNA expression level was significantly correlated with TNM stage (
χ2=4.363,
P<0.05), tumor diameter (
χ2=6.626,
P<0.05) and lymph node metastasis (
χ2=4.949,
P<0.05) in PC patients. The protein level of RBM15B in PC cell line (SW1990: 3.34±0.44; HPAFII: 2.76±0.32) was significantly higher than that in normal pancreatic cell line (HPDE: 0.81±0.17), and the difference was statistically significant (
t=6.421, 4.779,
P<0.01). The absorbance of SW1990 cells in the low expression group at 72 h (1.02±0.11, 1.35±0.13) was significantly lower than that of the control group (1.96±0.14,
t=4.007, 3.748,
P<0.01). The number of colonies formed by SW1990 in the low expression group (64.57±4.77, 134.26±10.32) was significantly less than that in the control group (193.74±19.58,
t=4.766, 3.595,
P<0.05). The number of SW1990 cells passing through the basement membrane in the low expression group (36.48±3.73, 47.68±4.29) was significantly less than that in the control group (105.32±13.23,
t=7.471, 4.617,
P<0.05). The results of RNA-seq enrichment analysis indicated that the differential genes were significantly enriched in the Hippo signaling pathway. The YAP expression level of SW1990 in the low expression group (1.78±0.12, 1.12±0.09) was significantly lower than that in the control group (2.45±0.21,
t=5.458, 6.897,
P<0.01). The TAZ expression level of SW1990 in the low expression group (1.35±0.08, 1.47±0.07) was significantly lower than that in the control group (2.13±0.17,
t=6.430, 3.791,
P<0.05).
Conclusion:The expression of RBM15B was significantly increased in PC tissues and cells as compared with paracancerous tissues and normal pancreatic cells, and was significantly correlated with TNM stage, tumor diameter, and lymph node metastasis. RBM15B promotes its proliferation, invasive ability through the Hippo pathway.